Your browser doesn't support javascript.
loading
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Kissling, Esther; Hooiveld, Mariëtte; Martínez-Baz, Iván; Mazagatos, Clara; William, Naoma; Vilcu, Ana-Maria; Kooijman, Marjolein N; Ilic, Maja; Domegan, Lisa; Machado, Ausenda; de Lusignan, Simon; Lazar, Mihaela; Meijer, Adam; Brytting, Mia; Casado, Itziar; Larrauri, Amparo; Murray, Josephine-L K; Behillil, Sylvie; de Gier, Brechje; Mlinaric, Ivan; O'Donnell, Joan; Rodrigues, Ana Paula; Tsang, Ruby; Timnea, Olivia; de Lange, Marit; Riess, Maximilian; Castilla, Jesús; Pozo, Francisco; Hamilton, Mark; Falchi, Alessandra; Knol, Mirjam J; Kurecic Filipovic, Sanja; Dunford, Linda; Guiomar, Raquel; Cogdale, Jade; Cherciu, Carmen; Jansen, Tessa; Enkirch, Theresa; Basile, Luca; Connell, Jeff; Gomez, Verónica; Sandonis Martín, Virginia; Bacci, Sabrina; Rose, Angela Mc; Pastore Celentano, Lucia; Valenciano, Marta.
Afiliação
  • Kissling E; Epiconcept, Paris, France.
  • Hooiveld M; Nivel, Utrecht, the Netherlands.
  • Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
  • Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • William N; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Vilcu AM; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
  • Kooijman MN; Public Health Scotland, Glasgow, United Kingdom.
  • Ilic M; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
  • Domegan L; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Machado A; Croatian Institute of Public Health, Zagreb, Croatia.
  • de Lusignan S; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
  • Lazar M; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
  • Meijer A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Brytting M; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom.
  • Casado I; "Cantacuzino" National Military Medical Institute for Research and Development, Bucharest, Romania.
  • Larrauri A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Murray JK; The Public Health Agency of Sweden, Stockholm, Sweden.
  • Behillil S; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
  • de Gier B; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Mlinaric I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • O'Donnell J; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
  • Rodrigues AP; Public Health Scotland, Glasgow, United Kingdom.
  • Tsang R; Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.
  • Timnea O; CNR des virus des infections respiratoires, Institut Pasteur, Paris, France.
  • de Lange M; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Riess M; Croatian Institute of Public Health, Zagreb, Croatia.
  • Castilla J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
  • Pozo F; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
  • Hamilton M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Falchi A; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom.
  • Knol MJ; "Cantacuzino" National Military Medical Institute for Research and Development, Bucharest, Romania.
  • Kurecic Filipovic S; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Dunford L; The Public Health Agency of Sweden, Stockholm, Sweden.
  • Guiomar R; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
  • Cogdale J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Cherciu C; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
  • Jansen T; Public Health Scotland, Glasgow, United Kingdom.
  • Enkirch T; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France.
  • Basile L; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Connell J; Croatian Institute of Public Health, Zagreb, Croatia.
  • Gomez V; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.
  • Sandonis Martín V; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
  • Bacci S; UK Health Security Agency, United Kingdom.
  • Rose AM; "Cantacuzino" National Military Medical Institute for Research and Development, Bucharest, Romania.
  • Pastore Celentano L; Nivel, Utrecht, the Netherlands.
  • Valenciano M; The Public Health Agency of Sweden, Stockholm, Sweden.
Euro Surveill ; 27(21)2022 05.
Article em En | MEDLINE | ID: mdl-35620997
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França